Cargando…

Identification of a potential diagnostic signature for postmenopausal osteoporosis via transcriptome analysis

Purpose: We aimed to establish the transcriptome diagnostic signature of postmenopausal osteoporosis (PMOP) to identify diagnostic biomarkers and score patient risk to prevent and treat PMOP. Methods: Peripheral blood mononuclear cell (PBMC) expression data from PMOP patients were retrieved from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Rui, Ke, Tian-Cheng, Ou, Mao-Ta, Duan, Li-Liang, Li, Yi, Chen, Zhi-Jing, Xing, Zhi-Bin, Fu, Xiao-Chen, Huang, Cheng-Yu, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464864/ https://www.ncbi.nlm.nih.gov/pubmed/36105211 http://dx.doi.org/10.3389/fphar.2022.944735

Ejemplares similares

The role of melatonin in the development of postmenopausal osteoporosis
por: Yang, Keda, et al.
Publicado: (2022)

Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis
por: Sun, Yang, et al.
Publicado: (2022)

Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis
por: Wang, Han, et al.
Publicado: (2023)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Identification of gene biomarkers in patients with postmenopausal osteoporosis
por: Yang, Chenggang, et al.
Publicado: (2019)

Overview on postmenopausal osteoporosis and periodontitis: The therapeutic potential of phytoestrogens against alveolar bone loss
por: Jayusman, Putri Ayu, et al.
Publicado: (2023)

Potential diagnostic value of PD‐1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients
por: Cai, Xiu‐Ping, et al.
Publicado: (2020)

Integrated Strategy of Network Pharmacological Prediction and Experimental Validation Elucidate Possible Mechanism of Bu-Yang Herbs in Treating Postmenopausal Osteoporosis via ESR1
por: Xia, Hanting, et al.
Publicado: (2021)

Mogrol Attenuates Osteoclast Formation and Bone Resorption by Inhibiting the TRAF6/MAPK/NF-κB Signaling Pathway In vitro and Protects Against Osteoporosis in Postmenopausal Mice
por: Chen, Yongjie, et al.
Publicado: (2022)

Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
por: Chen, Zhijie, et al.
Publicado: (2023)

Unveiling the Pharmacological Mechanisms of Eleutheroside E Against Postmenopausal Osteoporosis Through UPLC-Q/TOF-MS-Based Metabolomics
por: Ma, Yong-Sheng, et al.
Publicado: (2020)

Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
por: You, Ruxu, et al.
Publicado: (2020)

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
por: Johnson, Ben, et al.
Publicado: (2021)

Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma
por: Li, Gao, et al.
Publicado: (2021)

Recent Progresses in the Treatment of Osteoporosis
por: Li, Shan-Shan, et al.
Publicado: (2021)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women
por: Li, Na, et al.
Publicado: (2013)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Chinese Herbal Medicine Usage Reduces Overall Mortality in HIV-Infected Patients With Osteoporosis or Fractures
por: Ho, Mao-Wang, et al.
Publicado: (2021)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
por: Zhao, ChenLu, et al.
Publicado: (2023)

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
por: Jiang, Rui, et al.
Publicado: (2023)

Identifying microbial signatures for patients with postmenopausal osteoporosis using gut microbiota analyses and feature selection approaches
por: Huang, Dageng, et al.
Publicado: (2023)

Osteoprotective Effects in Postmenopausal Osteoporosis Rat Model: Oral Tocotrienol vs. Intraosseous Injection of Tocotrienol-Poly Lactic-Co-Glycolic Acid Combination
por: Ibrahim, Nurul ‘Izzah, et al.
Publicado: (2021)

Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis
por: Yuan, Wei, et al.
Publicado: (2022)

Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis
por: Lin, Chujiao, et al.
Publicado: (2019)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
por: Tian, Xiong, et al.
Publicado: (2022)

Fecal and Serum Metabolomic Signatures and Microbial Community Profiling of Postmenopausal Osteoporosis Mice Model
por: Wen, Kaicheng, et al.
Publicado: (2020)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy
por: Yang, Xiaolin, et al.
Publicado: (2023)

Association of inflammatory markers with all-cause mortality and cardiovascular mortality in postmenopausal women with osteoporosis or osteopenia
por: Qu, Li, et al.
Publicado: (2023)

Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis
por: Li, Qian, et al.
Publicado: (2023)

Systemic immune‐inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture
por: Fang, Hong, et al.
Publicado: (2019)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
por: Yang, Yi‐ran, et al.
Publicado: (2019)

Kidney tonifying traditional Chinese medicine: Potential implications for the prevention and treatment of osteoporosis
por: Duan, Yan, et al.
Publicado: (2023)

Ginsenoside Rg1 interferes with the progression of diabetic osteoporosis by promoting type H angiogenesis modulating vasculogenic and osteogenic coupling
por: Chen, Wenhui, et al.
Publicado: (2022)

Effects of Simultaneous Downregulation of PHD1 and Keap1 on Prevention and Reversal of Liver Fibrosis in Mice
por: Liu, Jing, et al.
Publicado: (2018)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Applying vibration in early postmenopausal osteoporosis promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells and suppresses postmenopausal osteoporosis progression
por: Li, Huiming, et al.
Publicado: (2019)

The Combined Effect of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome on Osteoporosis in Postmenopausal Females in Eastern China
por: Chen, Da-Zhi, et al.
Publicado: (2018)

Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis
por: Chen, Chia-Hsien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rss27p49jdqeu2n07rtpon3813